Nir Naor is Director of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 31,465 shares of BCLI, which is worth approximately $67,335. The most recent transaction as insider was on Jan 01, 2025, when has been sold 30,666 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.5K
162.23% 3M change
162.23% 12M change
Total Value Held $67,335

Nir Naor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2025
BUY
Grant, award, or other acquisition
-
30,666 Added 49.36%
31,465 Common Stock
Jun 19 2023
BUY
Grant, award, or other acquisition
-
11,999 Added 50.0%
11,999 Common Stock

Also insider at

AXGN
Axogen, Inc. Healthcare
NN

Nir Naor

Director
New York, NY

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Track Activities on BCLI